Form 4: Cytosorbents CFO Peter Mariani Increases Stake with Open Market Purchases

Cytosorbents' Chief Financial Officer, Peter Mariani, has recently acquired additional shares of the company's common stock through open market purchases.

Summary

• Peter Mariani, the Chief Financial Officer of Cytosorbents Corp, has reported purchasing shares of the company's common stock on the open market.
• On December 11, 2024, he acquired 11,363 shares at a weighted average price of $0.8891 per share.
• On December 12, 2024, he acquired an additional 20,000 shares at a weighted average price of $0.8936 per share.
• Following these transactions, Mr. Mariani directly owns 381,363 shares of Cytosorbents common stock.
• This total includes 31,363 shares of common stock and 340,000 restricted stock units (RSUs) that will convert to common stock upon vesting.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to the CFO's open market purchases, which signal confidence. However, it's not a major event, hence the score is not higher.

Positives

• The CFO's open market purchases demonstrate confidence in the company's future prospects.
• The increased stake aligns the CFO's interests with those of other shareholders.
• The purchases were made at prices ranging from $0.8289 to $0.92 on December 11 and $0.88 to $0.90 on December 12.

Industry Context

Insider buying is often seen as a positive signal in the market, suggesting that company leadership believes the stock is undervalued.

Comparison to Industry Standards

• Insider trading activity is a common metric used to gauge management's confidence in a company's prospects.
• Comparing this activity to similar biotech companies would provide further context, but this document does not provide that information.
• Generally, open market purchases by executives are viewed more favorably than sales.

Stakeholder Impact

• Shareholders may view the CFO's purchases as a positive sign, potentially increasing investor confidence.
• The purchases could have a minor positive impact on the stock price.

Key Dates

Keywords

Cytosorbents, CTSO, Peter Mariani, CFO, insider trading, share purchase, open market, restricted stock units, RSU